Brazilian Outlook

FDA Staff Question Peptides Backed by Kennedy Ahead of Review



US FDA ​staff reviewers said there is little evidence to allow compounding pharmacies to manufacture seven popular peptides, in ‌stark contrast to Health Secretary Robert F. Kennedy, Jr., who has publicly endorsed the compounds and said he is a “big fan.”

Please sign in to ensure you can read our agenda-setting intelligence, analysis and advice.
Or get in touch at support@businessoffashion.com
if you experience difficulties.



Source link

Leave a Reply

Your email address will not be published. Required fields are marked *